Reducing expenditures for statin-type lipid-lowering agents.
出版信息
Am J Health Syst Pharm. 1998 May 15;55(10):995-6, 999. doi: 10.1093/ajhp/55.10.995.
PMID:9606450
Abstract
摘要
相似文献
1
Reducing expenditures for statin-type lipid-lowering agents.降低他汀类降脂药物的支出。
Am J Health Syst Pharm. 1998 May 15;55(10):995-6, 999. doi: 10.1093/ajhp/55.10.995.
2
[Which statin is more efficient? Concepts and applications in economic evaluation].[哪种他汀类药物更有效？经济评估中的概念与应用]
Aten Primaria. 2000 Sep 30;26(5):333-8. doi: 10.1016/s0212-6567(00)78676-8.
3
Managed care trends in statin usage.他汀类药物使用中的管理式医疗趋势。
Manag Care. 2001 Oct;10(10):48-50, 53-9.
4
Cost-benefit analysis of lipid lowering therapy.降脂治疗的成本效益分析
Eur Heart J. 1996 Jul;17(7):974-5. doi: 10.1093/oxfordjournals.eurheartj.a015014.
5
Efficacy of low-density-lipoprotein lowering with statins.
Lancet. 1994 Sep 3;344(8923):683-4.
6
Cost-benefit analysis of lipid lowering therapy.降脂治疗的成本效益分析。
Eur Heart J. 1997 Jan;18(1):165-6. doi: 10.1093/oxfordjournals.eurheartj.a015099.
7
Efficacy of low-density-lipoprotein lowering with statins.
Lancet. 1994 Sep 3;344(8923):683.
8
Treating hyperlipidemia for the primary prevention of coronary disease. Are higher dosages of lovastatin cost-effective?治疗高脂血症以预防冠心病。更高剂量的洛伐他汀是否具有成本效益？
Arch Intern Med. 1998 Feb 23;158(4):375-81. doi: 10.1001/archinte.158.4.375.
9
Economics of lipid lowering with HMG CoA reductase inhibitors.使用HMG CoA还原酶抑制剂降低血脂的经济学分析。
Clin Cardiol. 1995 Jun;18(6):295, 363. doi: 10.1002/clc.4960180616.
10
Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin.
Lancet. 1994 Jun 18;343(8912):1554-5. doi: 10.1016/s0140-6736(94)92945-9.
Zotero 插件